Colonic Diseases, Functional
14
1
2
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
14%
2 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (14)
CRC Detection Reliable Assessment With Blood
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults
Adequacy of Anaesthesia for Colonoscopic Procedures
fMRI and Visceral Perception Upon Capsaicin Infusion
For Easy, Fast and Comfortable Colonoscopy, Which Position
Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery
Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS)
Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome
The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With Irritable Bowel Syndrome (IBS)
Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre?
Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)